中华创伤杂志(英文版)2024,Vol.27Issue(1) :11-17.DOI:10.1016/j.cjtee.2023.11.002

Advances in mesenchymal stem cells therapy for tendinopathies

Xu-Feng Mao Xi-Qian Zhang Zhe-Yu Yao Hai-Jiao Mao
中华创伤杂志(英文版)2024,Vol.27Issue(1) :11-17.DOI:10.1016/j.cjtee.2023.11.002

Advances in mesenchymal stem cells therapy for tendinopathies

Xu-Feng Mao 1Xi-Qian Zhang 1Zhe-Yu Yao 1Hai-Jiao Mao1
扫码查看

作者信息

  • 1. Department of Orthopaedic Surgery,The First Affiliated Hospital of Ningbo University,Ningbo,315010,Zhejiang province,China
  • 折叠

Abstract

Tendinopathies are chronic diseases of an unknown etiology and associated with inflammation.Mesenchymal stem cells(MSCs)have emerged as a viable therapeutic option to combat the pathological progression of tendinopathies,not only because of their potential for multidirectional differentiation and self-renewal,but also their excellent immunomodulatory properties.The immunomodulatory effects of MSCs are increasingly being recognized as playing a crucial role in the treatment of tendinopathies,with MSCs being pivotal in regulating the inflammatory microenvironment by modulating the immune response,ultimately contributing to improved tissue repair.This review will discuss the current knowledge regarding the application of MSCs in tendinopathy treatments through the modulation of the immune response.

Key words

Mesenchymal stem cells/Tendinopathy/Immunomodulation/Treatment/Review

引用本文复制引用

基金项目

Medical Health Project of the Health Department of Zhejiang Province(2021KY1045)

Ningbo Public Welfare Science and Technology Project(2021S104)

Ningbo Major Science and Technology Project(2022Z133)

Zhejiang Provincial Natural Science Foundation of China(LBY23H180002)

出版年

2024
中华创伤杂志(英文版)
中华医学会

中华创伤杂志(英文版)

CSTPCDCSCD
影响因子:0.608
ISSN:1008-1275
参考文献量99
段落导航相关论文